2013 Wisconsin Act 199 (2013-14 Assembly Bill 445): Requires individuals to show proper identification when picking up schedule II or III narcotic/opiate prescription medication in order to address prescription fraud and diversion.


2013 Wisconsin Act 200 (2013-14 Assembly Bill 446): Provides all levels of EMTs, first responders, police and fire the ability to be trained to administer Naloxone Narcan, a drug used to counter the effects of opiate overdose, such as a heroin overdose. Any person who administers the drug is immune from civil or criminal liability provided their actions are consistent with Wisconsin’s Good Samaritan law.


2013 Wisconsin Act 194 (2013-14 Assembly Bill 447): Provides limited immunity from certain criminal prosecutions for a person who seeks assistance from the police or medical professionals for another individual who has overdosed on controlled substances.


2013 Wisconsin Act 198 (2013-14 Assembly Bill 448): Encourages communities to set up drug disposal programs and regulates these programs so unwanted prescription drugs do not fall into the wrong hands.


2013 Wisconsin Act 197 (2013-14 Assembly Bill 668): Expands Treatment Alternatives and Diversion (TAD) programs by increasing funding by $1.5 million annually. Administered by the county, TAD has proven to be an effective and efficient means of combatting drug and alcohol abuse in our state.


2013 Wisconsin Act 195 (2013-14 Assembly Bill 701): Creates regional pilot programs to address opiate addiction in underserved areas. The treatment programs will assess individuals to determine treatment needs, provide counseling, and medical or abstinence-based treatment. After individuals successfully complete the program, they will be transitioned into county-based or private post-treatment care.


2013 Wisconsin Act 196 (2013-14 Assembly Bill 702): Creates a system of immediate punishments for individuals who violate their parole or probation parolees based on so-called “swift and certain” laws in other states. The model is based on research that shows that it’s the swiftness and the certainty of the sanction, not the length of the confinement, which has the greatest impact on influencing an offender’s behavior.


2015 Wisconsin Act 115 (2015-16 Assembly Bill 427): Expands Wisconsinites’ access to opioid antagonists like Narcan by offering the drug for purchase from certain pharmacies without a prescription via standing order.


2015 Wisconsin Act 266 (2015-16 Assembly Bill 364): Changes the requirement for those who dispense certain prescription drugs to submit information to the PDMP from 7 days to 24 hours. It will also require a practitioner to review a patient’s record when initially prescribing a monitored prescription drug (for example, a Schedule II drug).


2015 Wisconsin Act 268 (2015-16 Assembly Bill 365): States that when law enforcement encounters an inappropriate use or an infraction of the law concerning scheduled drugs, they upload that information into the PDMP and have the PDMP notify the physician. There are exceptions for on-going investigations.


2015 Wisconsin Act 265 (2015-16 Assembly Bill 366): Gives the Department of Health Services (DHS) oversight over the operation of pain management clinics across the state. The department’s oversight would not be regulatory, but would be a way of providing safeguards so “pill mills” don’t pop up in our state.


2015 Wisconsin Act 262 (2015-16 Assembly Bill 367): Requires methadone clinics to gather data such as staffing ratios, the number of patients receiving behavioral health services with the medication, and average mileage an individual is traveling to come to a clinic. This information will then be reported to DHS on an annual basis to give public health and treatment professionals a chance to analyze outcome data.


2015 Wisconsin Act 338 (2015-16 Assembly Bill 657): Allocates $2 million each fiscal year to go toward Treatment and Diversion (TAD) programs. These programs are alternatives for individuals charged with certain crimes to prosecution and incarceration. The individuals enrolled in the program will have the chance to receive the help and support they need in order to become and remain contributing members of society.


2015 Wisconsin Act 264 (2015-16 Assembly Bill 658): Criminalizes the use, possession, manufacture, distribution, and advertisement of any substance or device that is intended to defraud, circumvent, interfere with, or provide a substitute for a bodily fluid in conjunction with a lawfully administered drug test. Given that many employers subject their employees to lawfully administered drug tests, this bill will help ensure that people are not defrauding or interfering with the test results.


2015 Wisconsin Act 263 (2015-16 Assembly Bill 659): State regulations regarding opioid treatment programs are much more stringent than federal regulations. In order to afford more people accessibility to the treatment they need, this bill streamlines Wisconsin’s state regulations to align with federal regulations. With these changes, more Wisconsinites will be able to have access to opioid treatment.


2015 Wisconsin Act 269 (2015-16 Assembly Bill 660): Allows a number of medical-affiliated boards under the Department of Safety and Professional Services (DSPS) to issue guidelines regarding best practices in prescribing controlled substances. These best practices will help reduce instances of overprescribing and, in turn, lessen prescription opioid misuse, abuse, and addiction.


2015 Wisconsin Act 267 (2015-16 Assembly Bill 766): Creates reporting requirements for the Prescription Drug Monitoring Program (PDMP).The data collected will be reviewed and evaluated by the Controlled Substances Board (CSB) to determine the effectiveness of the PDMP and to compare actual outcomes with projected outcomes.